Journal of Heterocyclic Chemistry · 1989 · 29 citations · 4 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryHemostasisSynthetic Medicinal ChemistryAntiplatelet TherapyPlatelet FunctionPlatelet PhysiologyAntihypertensive Drug TherapyAntihypertensive PharmacologyAntiplatelet DrugsChemical ModificationPlatelet Aggregation InhibitionPlatelet AggregometryQuinoxaline ChemistryQuinoxaline Synthesis
Abstract Starting with 3‐amino‐2‐quinoxalinecarbonitrile 1,4‐dioxide 1 , a new series of quinoxaline derivatives 2‐12 was synthetized through chemical modification of the 3‐amino group, the 2‐cyano group and selective mono‐deoxygenation of the 1‐oxide or 4‐oxide groups. On the other hand, two 2,4‐diaminopyrimido[4,5‐ b ]quinoxa‐line derivatives 13, 14 were obtained condensing 3‐amino‐2‐quinoxaline carbonitriles with quanidine. Some of the new compounds were studied as inhibitors of blood platelet aggregation as well as antihypertensive agents.
4
Antonio Monge, P. Parrado, Marı́a Font et al. · Journal of Medicinal Chemistry · 1987 · 54 citations